EDWARDS LIFESCIENCES CORPORATION Calendar Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.28 USD | -1.07% |
|
-5.22% | -5.07% |
| Jan. 14 | Edwards Lifesciences Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 11:15 AM | |
| Jan. 10 | Pulse Biosciences Names Paul LaViolette CEO | MT |
Chart calendar Edwards Lifesciences Corporation
43cfbd20d47ead2c8cc637169a7319e.Xh35rsinyLp-W8NE4onzRivjWzPu4EW7ht1MUIixXBk.KFSP8bjvse8uEYozpc2nDnmRCFKLsT-IwaofFsTcL2AXQrbFv_Wr3CsOjg~fd77cdb394cb098b8915f6b39d01aa21
Upcoming events on Edwards Lifesciences Corporation
Past events on Edwards Lifesciences Corporation
| 2025-01-14 02:15 pm | JP Morgan Healthcare Conference |
| 2024-12-04 08:30 am | Investor Meeting |
| 2024-10-30 02:00 pm | Analyst & Investor Meeting - TMTT Q&A Session at TCT |
| 2024-10-28 04:00 pm | Analyst & Investor Meeting - TAVR Q&A Session at TCT |
| 2024-10-24 05:30 pm | Q3 2024 Earnings Call |
| 2024-10-24 04:21 pm | Q3 2024 Earnings Release |
| 2024-09-05 10:15 am | Wells Fargo Healthcare Conference |
| 2024-07-24 05:00 pm | Q2 2024 Earnings Call |
| 2024-07-24 04:15 pm | Q2 2024 Earnings Release |
| 2024-06-05 10:30 am | Jefferies Global Healthcare Conference |
| 2024-06-04 01:00 pm | William Blair Growth Stock Conference |
| 2024-05-07 01:00 pm | Annual General Meeting |
| 2024-04-25 05:00 pm | Q1 2024 Earnings Call |
| 2024-04-25 04:15 pm | Q1 2024 Earnings Release |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2024-02-06 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-06 04:15 pm | Q4 2023 Earnings Release |
| 2024-01-09 02:15 pm | JPMorgan Healthcare Conference |
| 2023-12-07 11:30 am | Investor Conference |
| 2023-10-26 05:30 pm | Analyst & Investor Meeting - TMTT Q&A Session at TCT |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5 233 5 255 -0.43% | 5 382 5 365 0.32% | 6 005 5 972 0.55% | 5 907 | 5 847 | 6 462 |
|
EBITDA Million USD | Released Forecast Spread | 1 729 1 766 -2.07% | 1 936 1 942 -0.31% | 1 879 1 904 -1.34% | 1 796 | 1 789 | 2 018 |
|
EBIT Million USD | Released Forecast Spread | 1 595 1 622 -1.73% | 1 797 1 789 0.4% | 1 734 1 754 -1.15% | 1 654 | 1 632 | 1 842 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 702 1 585 7.4% | 1 767 1 740 1.55% | 1 598 1 658 -3.62% | 1 593 | 1 760 | 1 906 |
|
Net income Million USD | Released Forecast Spread | 1 503 1 437 4.63% | 1 522 1 498 1.56% | 1 402 1 399 0.22% | 1 382 | 1 409 | 1 587 |
|
EPS USD | Released Forecast Spread | 2,38 2,30 3.3% | 2,44 2,39 2.16% | 2,30 2,29 0.34% | 2,31 | 2,39 | 2,70 |
| Announcement Date | 26/01/22 | 31/01/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 460 1 394 4.69% | 1 530 1 505 1.67% | 1 481 1 480 0.05% | 1 534 1 499 2.34% | 1 598 1 572 1.68% | 1 632 1 653 -1.26% | 1 354 1 368 -1.01% | 1 358 | 1 414 | 1 462 | 1 452 | 1 487 | 1 538 | 1 596 | 1 601 |
|
EBITDA Million USD | Released Forecast Spread | 469 471 -0.4% | 486 495 -1.88% | 459 458 0.08% | 465 489 -4.95% | 478 494 -3.38% | 486 523 -7.14% | 460 419 9.86% | 385 | 423 | 441 | 441 | 447 | 458 | 494 | 492 |
|
EBIT Million USD | Released Forecast Spread | 434 434 0.02% | 450 456 -1.38% | 422 419 0.64% | 428 446 -3.95% | 439 450 -2.35% | 446 481 -7.17% | 426 376 13.22% | 350 | 387 | 406 | 405 | 412 | 420 | 461 | 457 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 399 431 -7.62% | 339 449 -24.63% | 439 425 3.25% | 422 445 -5.24% | 409 450 -9.07% | 387 490 -21.09% | 403 | 359 | 395 | 421 | 422 | 447 | 439 | 464 | 477 |
|
Net income Million USD | Released Forecast Spread | 341 371 -8.1% | 307 375 -18.06% | 385 345 11.45% | 370 385 -3.97% | 352 379 -7.07% | 366 412 -11.1% | 3 071 340 804.32% | 315 | 333 | 352 | 353 | 365 | 376 | 396 | 402 |
|
EPS USD | Released Forecast Spread | 0,56 0,60 -7.24% | 0,50 0,61 -17.89% | 0,63 0,56 12.17% | 0,61 0,63 -3.13% | 0,58 0,63 -7.23% | 0,61 0,68 -10.39% | 5,13 0,54 854.95% | 0,53 | 0,56 | 0,60 | 0,60 | 0,62 | 0,63 | 0,68 | 0,68 |
| Announcement Date | 26/04/23 | 26/07/23 | 25/10/23 | 06/02/24 | 25/04/24 | 24/07/24 | 24/10/24 | - | - | - | - | - | - | - | - |
| 2025-01-23 04:05 pm | INTUITIVE SURGICAL, INC.: Q4 2024 Earnings Release |
| 2025-01-28 | REVVITY, INC.: Q4 2024 Earnings Release (Projected) |
| 2025-01-29 06:00 am | DANAHER CORPORATION: Q4 2024 Earnings Release |
| 2025-01-29 | EDWARDS LIFESCIENCES CORPORATION: Q4 2024 Earnings Release (Projected) |
| 2025-01-30 06:00 am | THERMO FISHER SCIENTIFIC INC.: Q4 2024 Earnings Release |
| 2025-01-30 04:05 pm | RESMED, INC.: Q2 2025 Earnings Release |
| 2025-01-30 | FUKUDA DENSHI CO., LTD.: Q3 2024 Earnings Release |
| 2025-02-04 | NIHON KOHDEN CORPORATION: Q3 2024 Earnings Release |
| 2025-02-05 06:30 am | BOSTON SCIENTIFIC CORPORATION: Q4 2024 Earnings Release |
| 2025-02-05 04:01 pm | HOLOGIC, INC.: Q1 2025 Earnings Release |
Past sector events for Edwards Lifesciences Corporation
| 2025-01-13 02:00 am | OXFORD NANOPORE TECHNOLOGIES PLC: Q4 2024 Sales and Revenue Release - Trading Update |
| 2024-12-11 01:00 am | CARL ZEISS MEDITEC AG: Q4 2024 Earnings Release |
| 2024-11-27 01:30 am | ELEKTA AB: Q2 2025 Earnings Release |
| 2024-11-25 04:05 pm | AGILENT TECHNOLOGIES, INC.: Q4 2024 Earnings Release |
| 2024-11-07 | OLYMPUS CORPORATION: Q2 2025 Earnings Release |
| 2024-11-07 07:00 am | AXOGEN, INC.: Q3 2024 Earnings Release |
| 2024-11-06 | CLASSYS INC.: Q3 2024 Earnings Release |
| 2024-11-06 | NIHON KOHDEN CORPORATION: Q2 2024 Earnings Release |
| 2024-11-06 01:36 am | SIEMENS HEALTHINEERS AG: Q4 2024 Earnings Release |
| 2024-11-05 04:05 pm | CYTEK BIOSCIENCES, INC.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EW Stock
- Calendar Edwards Lifesciences Corporation